이 치료 시장 규모, 점유율, 성장 분석 : 제품 유형별, 유형별, 투여 경로별, 증상별, 제형별, 유통 채널별, 지역별 - 업계 예측(2026-2033년)

Global Lice Treatment Market size was valued at USD 2.35 Billion in 2024 and is poised to grow from USD 2.51 Billion in 2025 to USD 4.29 Billion by 2033, growing at a CAGR of 6.9% during the forecast period (2026-2033).

The global lice treatment market is poised for significant growth driven by an increasing incidence of lice infestations, particularly due to factors like overcrowded schools and close community interactions. The convenience of over-the-counter treatments and advancements in product formulations further enhance market opportunities. Additionally, there is a rising demand for natural and non-toxic treatment options, largely influenced by concerns over the neurotoxicity associated with conventional pesticide-based products. The growth of online retail platforms has also improved accessibility of treatments, benefitting market players. However, challenges such as the rising resistance of lice to chemical treatments, adverse side effects, limited access in low-income regions, and social stigma surrounding infestations may hinder market penetration and growth in the near future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Lice Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Lice Treatment Market Segments Analysis

Global Lice Treatment Market is segmented by Product Type, Type, Route of Administration, Condition, Dosage Form, Distribution Channel and region. Based on Product Type, the market is segmented into OTC products and Prescription medications. Based on Type, the market is segmented into Branded and Generic. Based on Route of Administration, the market is segmented into Oral and Topical. Based on Condition, the market is segmented into Pediculosis capitis, Pediculosis corporis and Pediculosis pubis. Based on Dosage Form, the market is segmented into Tablets, Shampoos, Lotions, Cream and Other dosage forms. Based on Distribution Channel, the market is segmented into Hospital pharmacies, Retail pharmacies and Other distribution channels. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Lice Treatment Market

The growth of the Global Lice Treatment market is significantly propelled by innovations in treatment formulations that enhance both efficacy and user safety. Modern products now feature non-pesticide and silicone-based solutions that immobilize lice physically, minimizing the reliance on neurotoxins and addressing resistance issues. These contemporary treatments are designed to be odorless and less irritating, while also requiring shorter application times, which greatly improves the overall user experience. As a result of these advancements, consumers develop greater trust and satisfaction, leading to increased repeat purchases and a positive outlook for the lice treatment market moving forward.

Restraints in the Global Lice Treatment Market

The Global Lice Treatment market faces significant challenges due to the increasing resistance of lice to traditional treatments. Previously reliable chemical agents such as permethrin and pyrethrin have seen diminished effectiveness due to over-application, leading to instances of treatment failure. This resistance not only frustrates consumers but also erodes trust in established brands, ultimately affecting repeat purchases. Additionally, the emergence of "super lice," which resist multiple chemical treatments, compounds the difficulties within the market. Consequently, there is a growing demand for alternative non-chemical solutions, which has impeded the growth of the lice treatment industry.

Market Trends of the Global Lice Treatment Market

The Global Lice Treatment market is witnessing a notable shift toward preventive care, as consumers increasingly prioritize proactive strategies to thwart lice infestations. This evolving trend is characterized by heightened demand for preventive products, including specially formulated shampoos, sprays, and combs infused with natural lice-repelling essential oils like rosemary and eucalyptus. Parents and educational institutions are adopting these preventive measures to ensure a lice-free environment, thereby broadening the market's scope beyond mere reactive treatments. This emphasis on long-term product usage reflects a growing awareness of lice prevention, ultimately transforming consumer behavior and driving innovation within the industry.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Lice Treatment Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• OTC products
  • Permethrin
  • Pyrethrin
  • Other OTC products
• Prescription medications
  • Ivermectin
  • Spinosad
  • Malathion
  • Other prescription medications

Global Lice Treatment Market Size by Type & CAGR (2026-2033)

• Market Overview
• Branded
• Generic

Global Lice Treatment Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Oral
• Topical

Global Lice Treatment Market Size by Condition & CAGR (2026-2033)

• Market Overview
• Pediculosis capitis
• Pediculosis corporis
• Pediculosis pubis

Global Lice Treatment Market Size by Dosage Form & CAGR (2026-2033)

• Market Overview
• Tablets
• Shampoos
• Lotions
• Cream
• Other dosage forms

Global Lice Treatment Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital pharmacies
• Retail pharmacies
• Other distribution channels

Global Lice Treatment Market Size & CAGR (2026-2033)

• North America (Product Type, Type, Route of Administration, Condition, Dosage Form, Distribution Channel)
  • US
  • Canada
• Europe (Product Type, Type, Route of Administration, Condition, Dosage Form, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Type, Route of Administration, Condition, Dosage Form, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Type, Route of Administration, Condition, Dosage Form, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Type, Route of Administration, Condition, Dosage Form, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Johnson & Johnson Services, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Reckitt Benckiser Group plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Perrigo Company plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Prestige Consumer Healthcare Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline (GSK) plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ParaPRO LLC. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alliance Pharma PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arbor Pharmaceuticals, LLC. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oystershell Consumer Health (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Taro Pharmaceuticals (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICB PHARMA (Poland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lice Clinics of America (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations